Intensive chemotherapy (codox-m/ivac) compares favorably with other regimens for HIV positive and negative patients with burkitt's lymphoma (BL) Article
Overview
publication date
- December 1, 2000
published in
- Blood Journal
Identity
Scopus Document Identifier
- 33748643596
Additional Document Info
volume
- 96
issue
- 11 PART I